FORESIGHT BIOTHERAPEUTICS
Foresight Biotherapeutics is a clinical-stage drug development company pioneering novel therapies designed to address significant unmet needs in ophthalmology and otolaryngology. Foresight’s platform Povidone-Iodine (PVP-I) technology represents an important breakthrough in the treatment of ocular and otic inflammation including bacterial, viral and fungal infections. This platform enables PVP-I, a well-characterized broad spectrum antiseptic with no known microbial resistance, to be formulated in combination with a range of anti-inflammatory agents.
FORESIGHT BIOTHERAPEUTICS
Industry:
Biotechnology Health Diagnostics Therapeutics
Founded:
2008-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.foresightbio.com
Total Employee:
1+
Status:
Active
Contact:
646-747-9100
Email Addresses:
[email protected]
Total Funding:
17 M USD
Technology used in webpage:
Domain Not Resolving
Current Employees Featured
Founder
Investors List
Integrin Partners
Integrin Partners investment in Venture Round - Foresight Biotherapeutics
